ClinicalTrials.Veeva

Menu

Patient Report Outcome and Oncological Safety -Oncoplastic and Conventional BCS Cohort

S

Shandong First Medical University

Status

Not yet enrolling

Conditions

Breast Cancer Female
Oncological Safety
Patient Reported Outcome
Breast-conserving Surgery

Treatments

Procedure: conventional breast-conserving surgery
Procedure: oncoplastic breast-conserving surgery

Study type

Observational

Funder types

Other

Identifiers

NCT05054777
ShandongCHI-18

Details and patient eligibility

About

Breast-conserving surgery (BCS) is the traditional surgical treatment for early-stage breast cancer patients. There are evidences indicating that oncoplastic BCS could improve cosmetic outcomes and/or quality of life, and has similar oncological safety as conventional BCS does. However, these studies that focused on patient-reported outcomes and oncological safety were mainly from one institution or of small sample size. The variations across hospitals and regions were not fully analyzed. A multicenter prospective patient report outcome (PROs) and oncological safety will be planned to assess the PROs and safety for Chinese breast cancer patients who will undergo oncoplastic and conventional breast-conserving surgery (OBCS). This study follows the Helsinki Declaration and Chinese rules. All patients will be asked to sign the informed consent and will be followed up 24 months after operations. All data will be collected.

Enrollment

5,000 estimated patients

Sex

Female

Ages

18 to 80 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Informed consent signed;
  2. Non-metastatic Breast cancer patients confirmed by pathology;
  3. Adult (>18 years old, <80 years old);
  4. Female;
  5. Must undergo oncoplastic or conventional breast-conserving surgery;

Exclusion criteria

  1. Inflammatory breast cancer, Stage IV breast cancer patients;
  2. Have other malignant tumors;
  3. Pregnancy women;
  4. Have severe co-morbidities that compromise the patients' compliance to our protocol, or endanger the patients;
  5. Refuse breast-conserving surgery.

Trial design

5,000 participants in 2 patient groups

oncoplastic breast-conserving surgery
Description:
The oncoplastic breast-conserving surgery were mainly those surgeries using volume displacement or volume replacement techniques
Treatment:
Procedure: oncoplastic breast-conserving surgery
conventional breast-conserving surgery
Description:
The conventional breast-conserving surgery were performed without any oncoplastic operations
Treatment:
Procedure: conventional breast-conserving surgery

Trial contacts and locations

0

Loading...

Central trial contact

Chao Li, MD; Zhiyong Yu, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems